Beyond Air (XAIR) Free Cash Flow (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.90% |
| Sep 30, 2025 | 88.95% |
| Jun 30, 2025 | 44.32% |
| Mar 31, 2025 | -285.43% |
| Dec 31, 2024 | 38.20% |
| Sep 30, 2024 | 72.44% |
| Jun 30, 2024 | -1.56% |
| Mar 31, 2024 | 16.48% |
| Dec 31, 2023 | 5.29% |
| Sep 30, 2023 | 10.85% |
| Jun 30, 2023 | -71.55% |
| Mar 31, 2023 | -14.43% |
| Dec 31, 2022 | -13.07% |
| Sep 30, 2022 | -13.92% |
| Jun 30, 2022 | 13.88% |
| Mar 31, 2022 | -240.15% |
| Dec 31, 2021 | 33.42% |
| Sep 30, 2021 | 211.74% |
| Jun 30, 2021 | 29.41% |
| Mar 31, 2021 | -3.44% |
| Dec 31, 2020 | -41.89% |
| Sep 30, 2020 | 33.53% |
| Jun 30, 2020 | -17.52% |
| Mar 31, 2020 | -2.25% |
| Dec 31, 2019 | -74.13% |
| Sep 30, 2019 | 6.01% |
| Jun 30, 2019 | -141.11% |
| Mar 31, 2019 | 527.57% |
| Dec 31, 2018 | 8.09% |
| Sep 30, 2018 | 21.75% |
| Jun 30, 2018 | -31.62% |
| Mar 31, 2018 | 65.85% |
| Dec 31, 2017 | -256.71% |
| Sep 30, 2017 | 17.74% |
| Jun 30, 2017 | 21.93% |
| Mar 31, 2017 | -707.80% |
| Dec 31, 2016 | -147.32% |
| Sep 30, 2016 | 0.88% |
| Jun 30, 2016 | 40.53% |